Suzhou, Jiangsu, China Related Funds
| Fund Name | Location |
| Background Capital | - |
| Borealis | Canada, Magog, Ontario |
| Breakaway Capital Partners | California, Los Angeles, United States |
| Computer Software Association of Japan | Chiyoda, Japan |
| Datt Capital | Australia, Melbourne, Victoria |
| Huawei Technologies | China, Guangdong, Shenzhen |
| L Capital Partners | New York, New York, United States |
| LAUDA | - |
| Micromax Informatics | Gurgaon, Haryana, India |
| Mitacs | British Columbia, Canada, Vancouver |
| NJTC Venture Fund | Mount Laurel, New Jersey, United States |
| OTS | Aichi Prefecture, Japan, Kasugai |
| Rambus | California, Los Altos, United States |
| Software Innovation | Akershus, Lysaker, Norway |
| STARTegy Ventures | Coahuila, Mexico, Monclova |
| United Fund | China, Hangzhou, Zhejiang |
Notable deals
| Company | Industry | Round Size | Date | Investors | Location |
Tyligand Bioscience | 08 Jul 2023 | Shanghai, Shanghai, China | |||
Levostar | 11 Apr 2022 | Suzhou, Jiangsu, China | |||
Singlomics | $46M | 02 Feb 2022 | Beijing, Beijing, China | ||
Shuimu BioSciences | $2M | 01 Jan 2020 | Dongcheng District, Beijing, China | ||
NeuralGalaxy | $6M | 09 Sep 2019 | Dongcheng District, Beijing, China | ||
Magic Medical | $1M | 12 Jun 2019 | Shanghai, Shanghai, China | ||
Immvira | $15M | 31 Jan 2019 | Futian District, Guangdong Province | ||
| 01 Jan 2018 | Jiang'an District, Hubei |
1. You post comments at your own choice and risk. You bear the whole responsibility,related to their substance, content and the fact of publication. We shall not bear anyliability in respect of such comments.
2. While commenting, you shall use only actual, truthful and confirmed data. In thesame time you shall not use vulgar, abusive or defamatory language as well as expresshatred or call to violence or cruelty.
3. We do not intend to delete any comments on the website unless within our “noticeand take down” procedure.
4. We can moderate comments at any time.
5. While commenting, you are under the rule of our website’s terms of use and privacypolicy.
6. We retain our right to delete any comment or any other content of the website at ourwill in case we know or suppose such content is illegal or breaches any lawful right.
Review
- No reviews are submitted yet.
Sign up and get access to full fund profile and advanced analysis.
Full teamIndustries heatmapStages heatmapGeorgaphy breakdownCoinvestorsPortfolio analysisPerformance indexesLatest highlights
Unlock all data Latest deals
| Company | Industry | Round Size | Date | Investors | Location |
Tyligand Bioscience | 08 Jul 2023 | Shanghai, Shanghai, China | |||
Levostar | 11 Apr 2022 | Suzhou, Jiangsu, China | |||
Singlomics | $46M | 02 Feb 2022 | Beijing, Beijing, China | ||
Shuimu BioSciences | $2M | 01 Jan 2020 | Dongcheng District, Beijing, China | ||
NeuralGalaxy | $6M | 09 Sep 2019 | Dongcheng District, Beijing, China | ||
Magic Medical | $1M | 12 Jun 2019 | Shanghai, Shanghai, China | ||
Immvira | $15M | 31 Jan 2019 | Futian District, Guangdong Province | ||
| 01 Jan 2018 | Jiang'an District, Hubei |
